← Eichor
Condition: Mastocytosis Systemic Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Mastocytosis Systemic

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

An Observational Study in Participants With Indolent Systemic Mastocytosis (ISM)
Phase N/A · 1 location(s) · Blueprint Medicines Corporation · NCT07264959
Avapritinib With Decitabine in Patients With SM-AHN
Phase 1 · 7 location(s) · H. Lee Moffitt Cancer Center and Research Institute · NCT06327685
Avapritinib Rollover Study
Phase 4 · 7 location(s) · Blueprint Medicines Corporation · NCT06748001
Registry of Older Patients With Cancer
Phase N/A · 7 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT01137825
Peripheral Blood KIT-D816V Mutation in Adult Systemic Mastocytosis
Phase N/A · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT07562542
3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
Phase N/A · 1 location(s) · Barbara Ann Karmanos Cancer Institute · NCT00935090
A Non-Interventional Study in Participants With Indolent Systemic Mastocytosis (ISM) in Germany
Phase N/A · 8 location(s) · Blueprint Medicines Corporation · NCT07255638
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers
Phase 2 · 10 location(s) · Fred Hutchinson Cancer Center · NCT03779854
Mastocytosis From Pediatric Age to Adulthood: Local Registry of Cutaneous and Systemic Mastocytosis
Phase N/A · 1 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT07142473
(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis
Phase 2/Phase 3 · 71 location(s) · Blueprint Medicines Corporation · NCT04910685
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Phase 2 · 42 location(s) · Cogent Biosciences, Inc. · NCT04996875
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Phase N/A · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT01137643
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.